N@N

Market Maker Surveillance Report. PVCT, CETV, REG, CBIS, MCIG, USRM, Highest Net Sell Volume and Negative Price Friction For W

March 1, 2017 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 5201 companies with "abnormal" market making, 4471 companies with positive Friction Factors and 2027 companies with negative Friction Factors. Here is a list of the top companies with the highest net sell volume on Wednesday and lowest negative price Friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Provectus Biopharmaceuticals Inc. (PINK:PVCT), Central European Media Enterprises Ltd. (NASDAQ:CETV), Regency Centers Corporation (NYSE:REG), CANNABIS SCIENCE Inc. (OTC:CBIS), MCIG Inc. (OTC:MCIG), U.S. Stem Cell Inc. (OTC:USRM). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  PVCT    $-0.012   -0.31%    2,750,308    29.95%    6,436,105    70.09%    -3,685,797   -3,046,113
  CETV    $-0.010   -0.00%    38,633       1.47%     2,516,806    95.56%    -2,478,173   -2,478,173
  REG     $-1.950   -0.03%    4,821,722    15.05%    7,729,056    24.12%    -2,907,334   -14,909 
  CBIS    $-0.010   -0.11%    31,397,974   38.79%    49,547,132   61.21%    -18,149,158  -18,149,158
  MCIG    $-0.043   -0.16%    4,342,455    37.69%    7,176,787    62.29%    -2,834,332   -659,147
  USRM    $-0.024   -0.46%    33,657,288   40.05%    50,379,068   59.95%    -16,721,780  -6,967,408

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have low price friction combined with more selling than buying (negative Net Volume) in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows PVCT down $-0.01210 with a Friction Factor of -3,046,113 and a Net Volume of -3,685,797. That means that it takes 3,046,113 more shares of selling than buying to drop PVCT by one penny. On Monday the Market Makers allowed the stock to move down on heavier selling than buying (low negative friction).

Provectus Biopharmaceuticals Inc. (PINK:PVCT) - Provectus Biopharmaceuticals, Inc., a biopharmaceutical company, engages in developing ethical pharmaceuticals for oncology and dermatology indications. Its prescription drug candidates includes PV-10, which is in Phase III study for cutaneous melanoma; completed Phase II study for metastatic melanoma; completed Phase I study for liver and breast cancers; and phase 1b/2 study for pembrolizumab. The company is also developing PH-10 that has completed Phase II randomized study for the treatment of psoriasis and atopic dermatitis. In addition, it develops PH-10 for the treatment of actinic keratosis and severe acne vulgaris. Further, the company is developing over-the-counter pharmaceuticals, including GloveAid, a hand cream with antiperspirant and antibacterial properties; Pure-ific line of products to prevent the spread of germs on skin; and Pure-Stick and Pure N Clear acne products. Additionally, it develops medical device technologies for markets comprising cosmetic treatments, such as reduction of wrinkles and elimination of spider veins, and other cosmetic blemishes; and therapeutic uses, including photoactivation of PH-10, other prescription drugs, and non-surgical destruction of various skin cancers. The company was formerly known as Provectus Pharmaceuticals, Inc. and changed its name to Provectus Biopharmaceuticals, Inc. in December 2013. Provectus Biopharmaceuticals, Inc. was founded in 2002 and is based in Knoxville, Tennessee..

Central European Media Enterprises Ltd. (NASDAQ:CETV) - Central European Media Enterprises Ltd. operates as a media and entertainment company in Central and Eastern Europe. The company operates in six segments: Bulgaria, Croatia, the Czech Republic, Romania, the Slovak Republic, and Slovenia. It broadcasts a total of 36 television channels, including general entertainment and other channels. The company also develops and produces content for their television channels; and provides premium television content through a series of portals, including through Voyo, a subscription based video-on-demand service, and advertising supported catch-up services on its Websites, as well as offers advertising services on its television channels for advertising agencies and sponsors. Central European Media Enterprises Ltd. was founded in 1994 and is based in Hamilton, Bermuda..

Regency Centers Corporation (NYSE:REG) - Regency Centers Corporation operates as a real estate investment trust. The company, through its subsidiaries, owns, operates, and develops community and neighborhood shopping centers that are tenanted by grocers, category-leading anchors, specialty retailers, and restaurants. As of December 31, 2006, it owned 218 retail shopping centers located in 22 states and held partial interests in 187 retail shopping centers through joint ventures located in 24 states and the District of Columbia. The company is qualified as a real estate investment trust (REIT) under the Internal Revenue Code. As a REIT, its net income would be exempt from federal taxation to the extent that it is distributed as dividends to shareholders. The company was founded in 1963 and is headquartered in Jacksonville, Florida..

CANNABIS SCIENCE Inc. (OTC:CBIS) - Cannabis Science, Inc., together with its subsidiaries, develops, produces, and commercializes phyto cannabinoid-based pharmaceutical products primarily in the United States. The company is involved in developing medicines for autism, blood pressure, cancer and cancer side effects, as well as for other illnesses comprising for general health maintenance. It also develops CS-TATI-1 for newly diagnosed and treatment-experienced patients with drug-resistant HIV strains, as well as those intolerant of available therapies; CS-S/BCC-1 to treat basal and squamous cell carcinomas; and a proprietary cannabis-based therapy for neurological conditions. In addition, the company offers an online video-based medical cannabis education system, including courses, such as medical cannabis law, medical marijuana, cooking, horticulture, and bud tending; and manufactures and distributes specialty horse and pet grooming and topical applications. It has a license agreement with Apothecary Genetics Investments LLC to produce various brand formulations for California medical cannabis market; and collaboration with IGXBio, Inc. to develop GenePro, a DNA-based immunotherapeutic drug. The company also has a collaborative research agreement with Dana Farber/Harvard Cancer Center to explore and develop cannabinoid medicines to fight cancer. Cannabis Science, Inc. is based in Colorado Springs, Colorado. Cannabis Science, Inc. is a subsidiary of Weedmaps Media, Inc..

MCIG Inc. (OTC:MCIG) - .

U.S. Stem Cell Inc. (OTC:USRM) - .

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net

Contributing Sources

---